Design and Synthesis of Cinanserin Analogs as Severe Acute Respiratory Syndrome Coronavirus 3CL Protease Inhibitors
Author:
Affiliation:
1. Shanghai Institute of Materia Medica, Chinese Academy of Sciences
2. School of Pharmacy, East China University of Science and Technology
Publisher
Pharmaceutical Society of Japan
Subject
Drug Discovery,General Chemistry,General Medicine
Link
http://www.jstage.jst.go.jp/article/cpb/56/10/56_10_1400/_pdf
Reference26 articles.
1. A Novel Coronavirus Associated with Severe Acute Respiratory Syndrome
2. Molecular Evolution of the SARS Coronavirus During the Course of the SARS Epidemic in China
3. Small molecules targeting severe acute respiratory syndrome human coronavirus
4. The Genome Sequence of the SARS-Associated Coronavirus
5. Characterization of a Novel Coronavirus Associated with Severe Acute Respiratory Syndrome
Cited by 26 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Synthesis, crystal structure, quantum computational, biological study, molecular docking and molecular dynamic simulations investigations on 2,2′-((1,4-phenylenebis(methylene)) bis(sulfanediyl))dianiline;Journal of Molecular Structure;2025-01
2. Structure and function of SARS-CoV and SARS-CoV-2 main proteases and their inhibition: A comprehensive review;European Journal of Medicinal Chemistry;2023-11
3. An Overview of Antivirals for Treating Lower Respiratory Tract Infections;Journal of the Mexican Chemical Society;2021-12-27
4. Synthetic and computational efforts towards the development of peptidomimetics and small-molecule SARS-CoV 3CLpro inhibitors;Bioorganic & Medicinal Chemistry;2021-09
5. Main Chemotypes of SARS-CoV-2 Reproduction Inhibitors;Russian Journal of Organic Chemistry;2021-05
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3